Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis. [electronic resource]
Producer: 20180530ISSN:- 1098-6596
- Adult
- Aged
- Anti-Bacterial Agents -- pharmacokinetics
- Azabicyclo Compounds -- pharmacokinetics
- Ceftazidime -- pharmacokinetics
- Cystic Fibrosis -- pathology
- Drug Combinations
- Female
- Humans
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Monte Carlo Method
- Prospective Studies
- Pseudomonas Infections -- drug therapy
- Pseudomonas aeruginosa -- drug effects
- Respiratory Tract Infections -- drug therapy
- Young Adult
- beta-Lactamase Inhibitors -- pharmacokinetics
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article
There are no comments on this title.
Log in to your account to post a comment.